Prostatis Group’s State Street Health Care Select Sector SPDR ETF XLV Stock Holding History
Bought
Maintained
Sold
Other funds holding XLV
Prostatis Group's XLV Position: Q1 2026 in Review
Prostatis Group sold out of State Street Health Care Select Sector SPDR ETF (XLV) in Q1 2026, closing a stake of 1,445 shares — an estimated $224K sold.
Prostatis Group first reported a position in XLV in Q1 2020 and held it in 19 quarters. The position peaked at $2.8M in Q4 2022. 1,815 funds tracked by Wall St. Rank hold XLV as of Q1 2026.
- Prostatis Group reported no remaining State Street Health Care Select Sector SPDR ETF position as of Q1 2026 after selling out during the quarter.
- Prostatis Group sold 1,445 State Street Health Care Select Sector SPDR ETF shares in Q1 2026, an estimated $224K.
- Prostatis Group first reported a position in State Street Health Care Select Sector SPDR ETF in Q1 2020 and held it in 19 quarters.
- Prostatis Group's State Street Health Care Select Sector SPDR ETF position peaked at $2.8M in Q4 2022.
- 1,815 funds tracked by Wall St. Rank held State Street Health Care Select Sector SPDR ETF as of Q1 2026.
Based on Prostatis Group's 13F filing for Q1 2026, filed 12 May 2026.